Volume: 5 Issue: 1
Year: 2017, Page: 35-38,
Background: Herpes simplex virus type 2 (HSV2) transmitted via sexual route is now the most common cause of genital ulcers in developed and developing countries. Increasing evidence demonstrates a substantial link between the epidemics of sexually transmitted HIV1 and HSV2 infection. HSV2 has an important role in acquiring and transmitting HIV through genital ulcers.
Aims & objective : This study was conducted to determine the seroprevalence of HSV2 in HIV seropositive individuals attending ICTC in a tertiary care hospital in Warangal and to study the sociodemographic factors influencing HSV2 seroprevalence in HIV seropositive subjects.
Materials and Methods :This descriptive study was performed among 200 HIV positive patients (case group) and 200 age and sex matched non- HIV patients ( control group) attending the ICTC in a tertiary care Hospital in Warangal. For the evaluation of HSV2 infection, blood samples were obtained and assessed for IgG antibody to HSV2 using ELISA method.The data was collected and analysed.
Results :Out of 200 cases,82 were seropositive for HSV2 (41%)in case group and 24 of 200 (12%) in control group. Seropositivity was 41.4% in female and 40.6% in male, 41.8% in under and 33.3% in age over 40 years.
Conclusion : It can be derived that the seroprevalence of HSV2 in HIV positive subjects in our region is high and makes persons with HIV infection one of the most appropriate target group for serological testing of HSV2 infection.
Keywords: Herpes simplex virus (HSV2), Human Immunodeficiency Virus (HIV), seroprevalence, seropositivity.
1. Andreoletti L, Piednoir E, Legoff J et al. High seroprevalence of herpes simplex virus type 2 infection in French human immunodeficiency virus infected outpatients. J Clin Microbiol. 2005; 43:4212-17.
2. Corey L. Herpes simplex virus. I n: Mandell G, Bennett J, Dolin R, editors. Principle and practice of infectious disease. 6th ed. Vol 2. Oxford; Elsevier Churchill Livingstone; 2005 pp; 1763-5.
3. O’Farrell N. Increasing prevalence of genital herpes in developing countries; implications for heterosexual HIV transmission and STI control programmes.Sex Transm Infect 1999; 75:377-84.
4. Corey L, Wald A, Celum CL, Quinn TC. The effects of herpes simplex virus 2 on HIV 1 acquisition and transmission; a review of two overlapping epidemics. J Acquir Immune Defic Syndr 2004 Apr 15;35(5):435-45.
5. Stamm W, Handsfield H, Rompalo A et al. The association between genital ulcer disease and acquisition of HIV infection in homosexual men. JAMA 1988; 260: 1429- 1433.
6. www.hivguidelines.org/clinical - guidelines/adults/ management of stis in hiv infected patients/genital herpes simplex virus . Oct 2007.
7. Bagdades E, Pillay D, Squires S et al. Relationship between herpes simplex virus ulceration and CD4+ cell counts in patients with HIV infection.AIDS 1992;6: 1317-1320.
8. Lara B. Strick, Anna wald and Connie Celum. Managament of herpes simplex virus type 2 infection in HIV type 1 infected persons. Clin Infect diseases 43;3:347-356.
9. Schacker T, Zeh J, Hu HL et al.Frequency of symptomatic and asymptomatic herpes simplex virus type 2 reactivations among immunodeficiency virus – infected men. J Infect Dis 1998; 178: 1616-1622.
10. Posavad CM, Wald A, Kuntz et al . Frequent reactivation of herpes simplex virus among HIV-1 infected patients treated with highly active anti-retroviral therapy.J. Infect. Dis 2004; 190: 693-696.
11. Schacker T, Zeh J, Hu H. Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression. J. Infect. Dis 2002; 186:1718-1725.
12. Nagot N, Ouedraogo A, Foulongue V et al. Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus. N.Engl.J.Med; 2007;356: 790-799.
13. Celum C, Levine R, Weaver M, Wald A. Genital herpes and human immunodeficiency virus; double trouble.Bull World Health Organ 2004 Jun 82(6): 447-53.
14. Alireza Janbakhash, MD, Feizollah Mansouri, MD et al. Seroepidemiology of herpes simplex virus type 2(HSV2) in HIV infected patients in Kermanshah- Iran. Caspian J Intern Med. 2012: 3(4); 546-549.
15. Safrin S, Ashley R, Houlihan C, Cusick PS, Mill J.Clinical and serologic features of herpes simplex virus infection in patients with AIDS.AIDS 1991: 5 (9); 1107-10.
16. Emonyi IW, Gray RH, Zenilman J, Schmidt E etal.Seroprevalence of herpes simplex virus type 2 (HSV2) in Rakai district, Uganda. East Afr Med J 2000; 77(8): 428- 30.
17. Rabenau HF, Buxbaum S, Preiser W, Weber B, Doerr HW. Seroprevalence of herpes simplex virus type 1 and type 2 in the Frankfurt am Main area, Germany, Med Microbiol Immunol(Berl) 2002; 190(4): 153-60.
18. Wutzler P, Doerr HW, Farber I, Eichhorn U, Helbig B etal. Seroprevalence of herpes simplex virus type 1 and type 2 in selected German populations- relevance for the incidence of genital herpes. J Med Virol 2000; 61(2): 201- 7.
19. BHB Van Benthem, J Spaargaren, JAR Vanden Hoek et al. Prevalence and risk factors of HSV-1 and HSV-2 antibodies in European HIV infected women. Sexually Transmitted Infections 2001;77:120-124.
20. Rawls WE, Gardner HL, Herpes genitalis, Venereal aspects. Clin Obstet Gynecol 1972; 15: 912-918.
21. Richard J Whitley. Herpes simplex Viruses.Fields Virology. David M.Knipe, Peter M, Howley Editors 4th ed, Lippincott Williams and Wilkins, 2001; 2474-2475.
22. Anna Wald, Rhoda Ashley- Morrow. Serological testing for Herpes simplex virus(HSV-1) and HSV-2 infection. Clin . Infect Dis 2002; 35:S173-S182.
Jyothi K, Sitamahalaxmi B, Sreedevi S. Seroepidemiological study of Herpes simplex virus 2 in Human Immunodeficiency Virus -1 seropositive individuals attending integrated counseling and testing centre in a tertiary care hospital in Warangal.Perspectives in medical research 2017;5(1):35-38.